Acadia Healthcare Company, Inc. (NASDAQ: ACHC) Stock Competitors & Peer Comparison
See ACHC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ACHC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACHC | $28.13 | -0.88% | 2.6B | 14.14 | $1.99 | N/A |
| HCA | $405.00 | -1.03% | 87.7B | 13.99 | $28.96 | +0.74% |
| THC | $265.05 | +0.59% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.66 | +0.85% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.79 | -0.65% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $183.99 | +1.28% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $169.65 | +0.26% | 10.3B | 7.53 | $22.54 | +0.47% |
| ENSG | $170.79 | -0.76% | 10B | 24.75 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $519.84 | -0.88% | 6.8B | 24.08 | $21.61 | +0.48% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
ACHC vs HCA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while HCA trades at $405.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas HCA's P/E ratio is 13.99. In terms of profitability, ACHC's ROE is -0.50%, compared to HCA's ROE of -1.13%. Regarding short-term risk, ACHC is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
ACHC vs THC Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while THC trades at $265.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas THC's P/E ratio is 15.37. In terms of profitability, ACHC's ROE is -0.50%, compared to THC's ROE of +0.51%. Regarding short-term risk, ACHC is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
ACHC vs FMS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while FMS trades at $22.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas FMS's P/E ratio is 8.52. In terms of profitability, ACHC's ROE is -0.50%, compared to FMS's ROE of +0.07%. Regarding short-term risk, ACHC is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
ACHC vs EHC Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while EHC trades at $121.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas EHC's P/E ratio is 20.85. In terms of profitability, ACHC's ROE is -0.50%, compared to EHC's ROE of +0.25%. Regarding short-term risk, ACHC is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
ACHC vs DVA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while DVA trades at $183.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas DVA's P/E ratio is 14.37. In terms of profitability, ACHC's ROE is -0.50%, compared to DVA's ROE of -1.24%. Regarding short-term risk, ACHC is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
ACHC vs UHS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while UHS trades at $169.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas UHS's P/E ratio is 7.53. In terms of profitability, ACHC's ROE is -0.50%, compared to UHS's ROE of +0.21%. Regarding short-term risk, ACHC is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
ACHC vs ENSG Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while ENSG trades at $170.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas ENSG's P/E ratio is 24.75. In terms of profitability, ACHC's ROE is -0.50%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, ACHC is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
ACHC vs OSH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas OSH's P/E ratio is -17.65. In terms of profitability, ACHC's ROE is -0.50%, compared to OSH's ROE of +4.64%. Regarding short-term risk, ACHC is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
ACHC vs CHE Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CHE trades at $519.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CHE's P/E ratio is 24.08. In terms of profitability, ACHC's ROE is -0.50%, compared to CHE's ROE of +0.29%. Regarding short-term risk, ACHC is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
ACHC vs PACS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while PACS trades at $42.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas PACS's P/E ratio is 22.49. In terms of profitability, ACHC's ROE is -0.50%, compared to PACS's ROE of +0.27%. Regarding short-term risk, ACHC is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
ACHC vs HIMS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while HIMS trades at $27.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas HIMS's P/E ratio is -43.31. In terms of profitability, ACHC's ROE is -0.50%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, ACHC is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
ACHC vs LHCG Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas LHCG's P/E ratio is 82.83. In terms of profitability, ACHC's ROE is -0.50%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, ACHC is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
ACHC vs LFST Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while LFST trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas LFST's P/E ratio is 95.88. In terms of profitability, ACHC's ROE is -0.50%, compared to LFST's ROE of +0.03%. Regarding short-term risk, ACHC is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
ACHC vs CON Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CON trades at $34.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CON's P/E ratio is 21.68. In terms of profitability, ACHC's ROE is -0.50%, compared to CON's ROE of +0.47%. Regarding short-term risk, ACHC is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
ACHC vs OPCH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while OPCH trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas OPCH's P/E ratio is 14.08. In terms of profitability, ACHC's ROE is -0.50%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, ACHC is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
ACHC vs NHC Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while NHC trades at $218.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas NHC's P/E ratio is 27.76. In terms of profitability, ACHC's ROE is -0.50%, compared to NHC's ROE of +0.13%. Regarding short-term risk, ACHC is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
ACHC vs AMED Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AMED's P/E ratio is 39.30. In terms of profitability, ACHC's ROE is -0.50%, compared to AMED's ROE of +0.11%. Regarding short-term risk, ACHC is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
ACHC vs AVAH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AVAH trades at $13.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AVAH's P/E ratio is 19.97. In terms of profitability, ACHC's ROE is -0.50%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, ACHC is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
ACHC vs BKD Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while BKD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas BKD's P/E ratio is -20.30. In terms of profitability, ACHC's ROE is -0.50%, compared to BKD's ROE of +4.06%. Regarding short-term risk, ACHC is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check BKD's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
ACHC vs GRDN Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while GRDN trades at $40.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas GRDN's P/E ratio is 35.79. In terms of profitability, ACHC's ROE is -0.50%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, ACHC is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
ACHC vs MD Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while MD trades at $27.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas MD's P/E ratio is 12.07. In terms of profitability, ACHC's ROE is -0.50%, compared to MD's ROE of +0.20%. Regarding short-term risk, ACHC is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
ACHC vs ADUS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while ADUS trades at $118.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas ADUS's P/E ratio is 17.78. In terms of profitability, ACHC's ROE is -0.50%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, ACHC is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
ACHC vs SEM Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas SEM's P/E ratio is 15.43. In terms of profitability, ACHC's ROE is -0.50%, compared to SEM's ROE of +0.08%. Regarding short-term risk, ACHC is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
ACHC vs ASTH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while ASTH trades at $38.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas ASTH's P/E ratio is 46.35. In terms of profitability, ACHC's ROE is -0.50%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, ACHC is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
ACHC vs SGRY Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while SGRY trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas SGRY's P/E ratio is 36.56. In terms of profitability, ACHC's ROE is -0.50%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, ACHC is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
ACHC vs AMEH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AMEH's P/E ratio is 39.25. In terms of profitability, ACHC's ROE is -0.50%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, ACHC is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
ACHC vs SNDA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while SNDA trades at $37.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas SNDA's P/E ratio is -6.09. In terms of profitability, ACHC's ROE is -0.50%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, ACHC is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
ACHC vs ARDT Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas ARDT's P/E ratio is 8.79. In terms of profitability, ACHC's ROE is -0.50%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, ACHC is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
ACHC vs HCSG Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while HCSG trades at $21.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas HCSG's P/E ratio is 17.46. In terms of profitability, ACHC's ROE is -0.50%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, ACHC is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
ACHC vs AGL Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AGL trades at $88.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AGL's P/E ratio is -5.72. In terms of profitability, ACHC's ROE is -0.50%, compared to AGL's ROE of -1.19%. Regarding short-term risk, ACHC is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
ACHC vs INNV Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while INNV trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas INNV's P/E ratio is -119.44. In terms of profitability, ACHC's ROE is -0.50%, compared to INNV's ROE of -0.09%. Regarding short-term risk, ACHC is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
ACHC vs NUTX Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while NUTX trades at $193.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas NUTX's P/E ratio is 7.65. In terms of profitability, ACHC's ROE is -0.50%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, ACHC is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
ACHC vs PNTG Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while PNTG trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas PNTG's P/E ratio is 28.79. In terms of profitability, ACHC's ROE is -0.50%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, ACHC is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
ACHC vs AMN Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AMN trades at $33.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AMN's P/E ratio is 11.23. In terms of profitability, ACHC's ROE is -0.50%, compared to AMN's ROE of +0.15%. Regarding short-term risk, ACHC is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
ACHC vs BKDT Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas BKDT's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, ACHC is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
ACHC vs USPH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while USPH trades at $79.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas USPH's P/E ratio is 31.25. In terms of profitability, ACHC's ROE is -0.50%, compared to USPH's ROE of -0.01%. Regarding short-term risk, ACHC is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
ACHC vs TALK Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas TALK's P/E ratio is 774.34. In terms of profitability, ACHC's ROE is -0.50%, compared to TALK's ROE of +0.00%. Regarding short-term risk, ACHC is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
ACHC vs GMRS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, GMRS has a market cap of 728.1M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while GMRS trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas GMRS's P/E ratio is 5.99. In terms of profitability, ACHC's ROE is -0.50%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, ACHC is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
ACHC vs EHAB Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas EHAB's P/E ratio is -197.14. In terms of profitability, ACHC's ROE is -0.50%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, ACHC is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
ACHC vs STLN Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while STLN trades at $5.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas STLN's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to STLN's ROE of +2.10%. Regarding short-term risk, ACHC is more volatile compared to STLN. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
ACHC vs TOI Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas TOI's P/E ratio is -14.25. In terms of profitability, ACHC's ROE is -0.50%, compared to TOI's ROE of +2.10%. Regarding short-term risk, ACHC is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
ACHC vs SRTA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while SRTA trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas SRTA's P/E ratio is -25.08. In terms of profitability, ACHC's ROE is -0.50%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, ACHC is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
ACHC vs MCTA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas MCTA's P/E ratio is 419.36. In terms of profitability, ACHC's ROE is -0.50%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, ACHC is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
ACHC vs CYH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CYH has a market cap of 406.8M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CYH trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CYH's P/E ratio is 3.95. In terms of profitability, ACHC's ROE is -0.50%, compared to CYH's ROE of +0.21%. Regarding short-term risk, ACHC is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
ACHC vs AUNA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AUNA has a market cap of 391.6M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AUNA trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AUNA's P/E ratio is 4.77. In terms of profitability, ACHC's ROE is -0.50%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, ACHC is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
ACHC vs VMD Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while VMD trades at $9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas VMD's P/E ratio is 25.22. In terms of profitability, ACHC's ROE is -0.50%, compared to VMD's ROE of +0.10%. Regarding short-term risk, ACHC is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
ACHC vs CSU Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CSU's P/E ratio is 0.67. In terms of profitability, ACHC's ROE is -0.50%, compared to CSU's ROE of -0.33%. Regarding short-term risk, ACHC is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
ACHC vs AIRS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AIRS's P/E ratio is -93.17. In terms of profitability, ACHC's ROE is -0.50%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, ACHC is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
ACHC vs JYNT Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while JYNT trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas JYNT's P/E ratio is 83.20. In terms of profitability, ACHC's ROE is -0.50%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, ACHC is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
ACHC vs FVE Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas FVE's P/E ratio is -5.64. In terms of profitability, ACHC's ROE is -0.50%, compared to FVE's ROE of -0.15%. Regarding short-term risk, ACHC is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
ACHC vs KDLYW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas KDLYW's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, ACHC is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
ACHC vs PARK Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while PARK trades at $20.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas PARK's P/E ratio is 27.61. In terms of profitability, ACHC's ROE is -0.50%, compared to PARK's ROE of -0.18%. Regarding short-term risk, ACHC is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
ACHC vs BTMD Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while BTMD trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas BTMD's P/E ratio is 14.05. In terms of profitability, ACHC's ROE is -0.50%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, ACHC is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
ACHC vs ALR Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas ALR's P/E ratio is -1.11. In terms of profitability, ACHC's ROE is -0.50%, compared to ALR's ROE of -0.15%. Regarding short-term risk, ACHC is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
ACHC vs DCGO Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while DCGO trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas DCGO's P/E ratio is -0.22. In terms of profitability, ACHC's ROE is -0.50%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, ACHC is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
ACHC vs CCEL Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CCEL trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CCEL's P/E ratio is -14.27. In terms of profitability, ACHC's ROE is -0.50%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, ACHC is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
ACHC vs IMAC Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas IMAC's P/E ratio is -2.27. In terms of profitability, ACHC's ROE is -0.50%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, ACHC is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
ACHC vs PIII Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while PIII trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas PIII's P/E ratio is -0.28. In terms of profitability, ACHC's ROE is -0.50%, compared to PIII's ROE of +1.61%. Regarding short-term risk, ACHC is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
ACHC vs EUDA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, EUDA has a market cap of 25.4M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while EUDA trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas EUDA's P/E ratio is -25.66. In terms of profitability, ACHC's ROE is -0.50%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, ACHC is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
ACHC vs PIIIW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas PIIIW's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, ACHC is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
ACHC vs CANO-WT Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, ACHC is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
ACHC vs AIH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AIH's P/E ratio is -2.78. In terms of profitability, ACHC's ROE is -0.50%, compared to AIH's ROE of +1.16%. Regarding short-term risk, ACHC is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
ACHC vs CANO Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CANO's P/E ratio is -0.01. In terms of profitability, ACHC's ROE is -0.50%, compared to CANO's ROE of -1.49%. Regarding short-term risk, ACHC is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
ACHC vs FPCG Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas FPCG's P/E ratio is 0.09. In terms of profitability, ACHC's ROE is -0.50%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, ACHC is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
ACHC vs FTRP Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas FTRP's P/E ratio is -1.22. In terms of profitability, ACHC's ROE is -0.50%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, ACHC is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
ACHC vs AMS Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AMS's P/E ratio is -5.66. In terms of profitability, ACHC's ROE is -0.50%, compared to AMS's ROE of -0.07%. Regarding short-term risk, ACHC is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
ACHC vs BMGL Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while BMGL trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas BMGL's P/E ratio is -0.91. In terms of profitability, ACHC's ROE is -0.50%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, ACHC is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
ACHC vs AIDX Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AIDX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AIDX's P/E ratio is -1.12. In terms of profitability, ACHC's ROE is -0.50%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, ACHC is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
ACHC vs MODV Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas MODV's P/E ratio is -0.06. In terms of profitability, ACHC's ROE is -0.50%, compared to MODV's ROE of +1.36%. Regarding short-term risk, ACHC is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check MODV's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
ACHC vs STLNW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, STLNW has a market cap of 5.5M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while STLNW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas STLNW's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, ACHC is more volatile compared to STLNW. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check STLNW's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
ACHC vs GBNH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas GBNH's P/E ratio is -0.06. In terms of profitability, ACHC's ROE is -0.50%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, ACHC is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
ACHC vs RHE-PA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, ACHC's ROE is -0.50%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, ACHC is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
ACHC vs RHE Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas RHE's P/E ratio is -1.79. In terms of profitability, ACHC's ROE is -0.50%, compared to RHE's ROE of -1.31%. Regarding short-term risk, ACHC is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
ACHC vs TOIIW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, ACHC's ROE is -0.50%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, ACHC is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
ACHC vs IMACW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas IMACW's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, ACHC is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
ACHC vs EDVA Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas EDVA's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to EDVA's ROE of N/A. Regarding short-term risk, ACHC is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
ACHC vs EUDAW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, ACHC's ROE is -0.50%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, ACHC is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
ACHC vs CCM Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while CCM trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas CCM's P/E ratio is -0.30. In terms of profitability, ACHC's ROE is -0.50%, compared to CCM's ROE of +0.06%. Regarding short-term risk, ACHC is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
ACHC vs NIVF Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while NIVF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas NIVF's P/E ratio is 0.56. In terms of profitability, ACHC's ROE is -0.50%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, ACHC is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
ACHC vs NIVFW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, NIVFW has a market cap of 45.5K. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, ACHC's ROE is -0.50%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, ACHC is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
ACHC vs MNDR Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while MNDR trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas MNDR's P/E ratio is -0.04. In terms of profitability, ACHC's ROE is -0.50%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, ACHC is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
ACHC vs TALKW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas TALKW's P/E ratio is 0.00. In terms of profitability, ACHC's ROE is -0.50%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, ACHC is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check TALKW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
ACHC vs SLHG Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas SLHG's P/E ratio is -1.48. In terms of profitability, ACHC's ROE is -0.50%, compared to SLHG's ROE of N/A. Regarding short-term risk, ACHC is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check SLHG's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
ACHC vs SLHGP Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, ACHC's ROE is -0.50%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, ACHC is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check SLHGP's competition here
Almost Family Inc. (NASDAQ: AFAM)
ACHC vs AFAM Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas AFAM's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, ACHC is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
ACHC vs TLMD Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas TLMD's P/E ratio is -1.60. In terms of profitability, ACHC's ROE is -0.50%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, ACHC is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check TLMD's competition here
Hanger, Inc. (NYSE: HNGR)
ACHC vs HNGR Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas HNGR's P/E ratio is 19.71. In terms of profitability, ACHC's ROE is -0.50%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, ACHC is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
ACHC vs NFH Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, NFH has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas NFH's P/E ratio is -19.75. In terms of profitability, ACHC's ROE is -0.50%, compared to NFH's ROE of -0.06%. Regarding short-term risk, ACHC is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
ACHC vs DVCR Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas DVCR's P/E ratio is 28.34. In terms of profitability, ACHC's ROE is -0.50%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, ACHC is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
ACHC vs ATIP-WT Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, ACHC is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check ATIP-WT's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
ACHC vs TLMDW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas TLMDW's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, ACHC is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check TLMDW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
ACHC vs TVTY Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas TVTY's P/E ratio is 19.06. In terms of profitability, ACHC's ROE is -0.50%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, ACHC is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
ACHC vs DCGOW Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas DCGOW's P/E ratio is N/A. In terms of profitability, ACHC's ROE is -0.50%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, ACHC is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for ACHC.Check DCGOW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
ACHC vs KND Comparison September 2026
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACHC stands at 2.6B. In comparison, KND has a market cap of 0. Regarding current trading prices, ACHC is priced at $28.13 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACHC currently has a P/E ratio of 14.14, whereas KND's P/E ratio is -1.14. In terms of profitability, ACHC's ROE is -0.50%, compared to KND's ROE of -0.53%. Regarding short-term risk, ACHC is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for ACHC.Check KND's competition here